<DOC>
	<DOCNO>NCT00315237</DOCNO>
	<brief_summary>The purpose clinical research study learn patient receive vinflunine plus best supportive care live long patient receive best supportive care alone . This study also investigate patient benefit , safety whether vinflunine shrink slow growth cancer .</brief_summary>
	<brief_title>Phase III Trial Vinflunine Plus Best Supportive Care vs. Best Supportive Care Patients With Transitional Cell Carcinoma ( TCC ) Urothelial Tract</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Bladder cancer Progressed 1st line platinumchemotherapy &gt; = 18 year old Adequate hematologic , hepatic &amp; renal function CNS disease Moderate neuropathy More 1 previous chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>